Diabetes mellitus and <i>APOL1</i> genotype increase the risk for chronic kidney disease progression in sickle cell disease

R Ryan Sun A Anand Srivastava J Joseph L. Zapater (3Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois Chicago, Chicago, IL) F Franklin Njoku (1University of Illinois Chicago, Chicago, United States) J Jin Han Z Zalaya Ivy (1Comprehensive Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL) M Marwah Farooqui (1University of Illinois College of Medicine, Chicago, United States) I Insia Rizvi (1Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL) B Brian Layden (University of Illinois Chicago, Chicago, Illinois, United States) R Robert E. Molokie (1Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL) V Victor R. Gordeuk S Santosh L. Saraf (1Comprehensive Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL)

Abstract

Abstract We observed diabetes mellitus (DM) in 9.3% of adults with sickle cell disease (SCD), and DM predicted a sevenfold greater risk of chronic kidney disease progression adjusting for high-risk APOL1. Our results emphasize the clinical significance of DM in SCD.

Article Details

Journal Blood
Volume / Issue Vol. 145, Issue 24
Published June 12, 2025
Pages 2927-2930
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (12)

R

Ryan Sun

A

Anand Srivastava

J

Joseph L. Zapater

3Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois Chicago, Chicago, IL

F

Franklin Njoku

1University of Illinois Chicago, Chicago, United States

J

Jin Han

Z

Zalaya Ivy

1Comprehensive Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL

M

Marwah Farooqui

1University of Illinois College of Medicine, Chicago, United States

I

Insia Rizvi

1Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL

B

Brian Layden

University of Illinois Chicago, Chicago, Illinois, United States

R

Robert E. Molokie

1Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL

V

Victor R. Gordeuk

S

Santosh L. Saraf

1Comprehensive Sickle Cell Center, Division of Hematology and Oncology, Department of Medicine, University of Illinois Chicago, Chicago, IL